|
JP2012001696A
|
|
Method for producing low molecular weight hyaluronic acid
|
|
JP2011057607A
|
|
Composition containing hyaluronic acid and hyaluronic acid oligo-saccharide
|
|
JP2009292767A
|
|
Nerve cell differentiation inducer
|
|
JP2007262103A
|
|
Remedy for osteoarthritis
|
|
JP2007277258A
|
|
Treating agent and prevention agent for inflammation and neurological disorder
|
|
JP2008267941A
|
|
Method for measuring molecular weight of hyaluronan, method for diagnosing disease, and kit for the same
|
|
JP2008214216A
|
|
Medicine for treating traumatic neuropathy and/or motility disturbance
|
|
JP2008127346A
|
|
Pharmaceutical for treatment and prevention of autoimmune diseases, inflammations and nervous diseases
|
|
JP2007126453A
|
|
Hyaluronan production promotor and hyaluronan decomposition suppressor
|
|
JP2009091248A
|
|
Therapeutic agent for traumatic neuropathy and/or motor function disorder
|
|
JP2007153797A
|
|
Therapeutic agent and preventive agent of autoimmune disease, inflammation, and nervous disease
|
|
JP2007153761A
|
|
Synapse transmission promoter and synapse protective agent
|
|
JP2007153766A
|
|
Expression enhancing agent of map kinase kinase kinase gene
|
|
JP2007106688A
|
|
Agent for suppressing expression of cytokine-related gene and chemokine-related gene
|
|
JP2007084509A
|
|
Cell activator
|
|
JP2006335694A
|
|
Treating agent for osteoarthritis
|
|
JP2006327958A
|
|
Remedy and prophylactic for autoimmune disease, inflammation, and nervous disease
|
|
JP2006327959A
|
|
Remedy for endocrine disease and metabolic disease
|
